Director & PRESIDENT AND CEO
Director & PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC., filing insider transactions between 2026-07-08 and 2026-09-11.
| SEC ↗ |
| 2026-09-10 | HALO | Sale | 14.6K | $107.01 | $1.6M | SEC ↗ |
| 2026-09-09 | HALO | Sale | 13.3K | $107.22 | $1.4M | SEC ↗ |
| 2026-09-09 | HALO | Sale | 6,596 | $107.82 | $711K | SEC ↗ |
| 2026-09-09 | HALO | Sale | 100 | $108.67 | $11K | SEC ↗ |
| 2026-08-19 | HALO | Sale | 3,200 | $107.77 | $345K | SEC ↗ |
| 2026-08-19 | HALO | Sale | 7,200 | $106.36 | $766K | SEC ↗ |
| 2026-08-19 | HALO | Sale | 9,600 | $107.22 | $1.0M | SEC ↗ |
| 2026-08-18 | HALO | Sale | 5,703 | $103.08 | $588K | SEC ↗ |
| 2026-08-18 | HALO | Sale | 4,897 | $104.11 | $510K | SEC ↗ |
| 2026-08-18 | HALO | Sale | 9,400 | $104.87 | $986K | SEC ↗ |
| 2026-08-17 | HALO | Sale | 7,500 | $103.48 | $776K | SEC ↗ |
| 2026-08-17 | HALO | Sale | 500 | $100.46 | $50K | SEC ↗ |
| 2026-08-17 | HALO | Sale | 900 | $98.96 | $89K | SEC ↗ |
| 2026-08-17 | HALO | Sale | 2,100 | $101.77 | $214K | SEC ↗ |
| 2026-08-17 | HALO | Sale | 9,000 | $102.55 | $923K | SEC ↗ |
| 2026-07-08 | HALO | Sale | 1,035 | $80.19 | $83K | SEC ↗ |
| 2026-07-08 | HALO | Sale | 888 | $79.28 | $70K | SEC ↗ |